Profusa (NVACW) Gains from Investment Securities (2022 - 2026)
Profusa posted quarterly Gains from Investment Securities of $14648.0 for Q1 2026, up 1564.8% year-on-year from $879.87 in Q1 2025, and up 101.61% on a QoQ basis from -$908000.0 in Q4 2025.
Profusa (NVACW) has 5 years of Gains from Investment Securities data on file, last reported at $14648.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 1564.8% year-over-year to $14648.0; the trailing twelve-month figure through Mar 2026 stood at $14648.0 (up 100.52% YoY), and the FY2025 full-year result was $12527.0, down 8.6% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $14648.0, up from -$908000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.9 million in Q2 2025 and bottomed at -$3.1 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is -$1000.0 (2025), against an average of -$52432.5.
- The widest annual swing landed in 2024, when Gains from Investment Securities tumbled 509.12%; it then jumped 1900.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$111338.0 in 2022, then tumbled by 359.02% to -$511069.0 in 2023, then sank by 509.12% to -$3.1 million in 2024, then soared by 70.83% to -$908000.0 in 2025, then jumped by 101.61% to $14648.0 in 2026.
- The last three Gains from Investment Securities figures came in at $14648.0 (Q1 2026), -$908000.0 (Q4 2025), and $4114.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profusa | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,648.00 |
| Mar 31, 2026 | 14,648.00 |
| Dec 31, 2025 | 2.49 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | 5.92 Mn |
| Mar 31, 2025 | 11,385.00 |
| Mar 31, 2025 | 11,385.00 |
| Dec 31, 2024 | -321,000.00 |
| Dec 31, 2024 | -321,000.00 |
| Sep 30, 2024 | 539,564.00 |
| Sep 30, 2024 | 539,564.00 |
| Jun 30, 2024 | 295,872.00 |
| Jun 30, 2024 | 295,872.00 |
| Mar 31, 2024 | 229,586.00 |
| Mar 31, 2024 | 229,586.00 |
| Dec 31, 2023 | -511,069.00 |
| Dec 31, 2023 | -511,069.00 |
| Sep 30, 2023 | 243,659.00 |
| Sep 30, 2023 | 243,659.00 |
| Jun 30, 2023 | -433,503.00 |
| Jun 30, 2023 | -433,503.00 |
| Mar 31, 2023 | 19,112.00 |
| Mar 31, 2023 | 19,112.00 |
| Dec 31, 2022 | -111,338.00 |
| Dec 31, 2022 | -111,338.00 |
| Sep 30, 2022 | -1.07 Mn |
| Sep 30, 2022 | -1.07 Mn |
| Jun 30, 2022 | -583,981.00 |
| Jun 30, 2022 | -583,981.00 |
| Mar 31, 2022 | -128,669.00 |
| Mar 31, 2022 | -128,669.00 |